General information about company |
Scrip Code* | 543321 |
NSE Symbol* | TATVA |
MSEI Symbol | NOTLISTED |
ISIN | INE0GK401011 |
Name of the listed entity | Tatva Chintan Pharma Chem Limited |
Date of start of financial year | 01-04-2023 |
Date of end of financial year | 31-03-2024 |
Date of Reporting to Exchange | 23-05-2024 |
Whether any observations reported by the Secretarial Auditor | No |
The listed entity has maintained proper records under the provisions of the above Regulations and circulars/ guidelines issued thereunder insofar as it appears from my/our examination of those records. | Yes |
In previous, Any actions taken against the listed entity/its promoters/directors/its material subsidiaries either by SEBI or by stock exchanges (including under the Standard operating procedures issued by SEBI through various circulars). | No |
Is there any observation made in the previous report | No |
Name of the Certifying Firm | TNT & ASSOCIATES |
Name of the practicing Company Secretary issuing the report | NIRAJ TRIVEDI |
Membership Type | FCS |
ACS/FCS No. | 3844 |
UDIN | F003844F000427971 |
CP No. | 3123 |
Place of PCS | VADODARA |
PCS Report Date | 23-05-2024 |
Regulations |
Sr No | Regulation | Applicability during the period under review (Yes/No) | Any Observation (Yes/No) |
1 | Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Yes | No |
2 | Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 | Yes | No |
3 | Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 | Yes | No |
4 | Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018 | No | No |
5 | Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 | No | No |
6 | Securities and Exchange Board of India (Issue and Listing of Non-Convertible Securities) Regulations, 2021 | No | No |
7 | Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 | Yes | No |
8 | Specify any other regulation applicable to the Company |
1 | Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 | Yes | No |
Affirmation |
Sr No | Regulation | Compliance status (Yes/No/NA) | Observations /Remarks by PCS* |
1 | Secretarial Standards:
The compliances of the listed entity are in accordance with the applicable Secretarial Standards (SS) issued by the Institute of Company Secretaries India (ICSI) | Yes | |
2 | Adoption and timely updation of the Policies |
(a) | All applicable policies under SEBI Regulations are adopted
with the approval of board of directors of the listed entities | Yes | |
(b) | All the policies are in conformity with SEBI Regulations and
has been reviewed & timely updated as per the
regulations/circulars/guidelines issued by SEBI | Yes | |
3 | Maintenance and disclosures on Website |
(a) | The Listed entity is maintaining a functional website | Yes | |
(b) | Timely dissemination of the documents/ information under
a separate section on the website | Yes | |
(c) | Web-links provided in annual corporate governance reports
under Regulation 27(2) are accurate and specific which re-directs to the relevant document(s)/ section of the website | Yes | |
4 | Disqualification of Director:
None of the Director of the Company are disqualified under
Section 164 of Companies Act, 2013 | Yes | |
5 | Details related to Subsidiaries of listed entities:
(a) Identification of material subsidiary companies
(b) Requirements with respect to disclosure of material as well as other subsidiaries | Yes | |
6 | Preservation of Documents:
The listed entity is preserving and maintaining records as prescribed under SEBI Regulations and disposal of records as per Policy of Preservation of Documents and Archival policy prescribed under SEBI LODR Regulations | Yes | |
7 | Performance Evaluation:
The listed entity has conducted performance evaluation of the
Board, Independent Directors and the Committees at the start
of every financial year as prescribed in SEBI Regulations | Yes | |
8 | Related Party Transactions |
(a) | The listed entity has obtained prior approval of Audit
Committee for all Related party transactions | Yes | |
(b) | In case no prior approval obtained, the listed entity shall
provide detailed reasons along with confirmation whether
the transactions were subsequently
approved/ratified/rejected by the Audit committee | NA | Prior Approval of all related Party Transactions were obtained from Audit Committee. |
9 | Disclosure of events or information:
The listed entity has provided all the required disclosure(s) under Regulation 30 along with Schedule III of SEBI LODR Regulations within the time limits prescribed thereunder | Yes | |
10 | Prohibition of Insider Trading:
The listed entity is in compliance with Regulation 3(5) & 3(6)
SEBI (Prohibition of Insider Trading) Regulations, 2015 | Yes | |
11 | Actions taken by SEBI or Stock Exchange(s), if any:
No Actions taken against the listed entity/ its promoters/directors/ subsidiaries either by SEBI or by Stock Exchanges (including under the Standard Operating Procedures issued by SEBI through various circulars) under SEBI Regulations and circulars/ guidelines issued thereunder (or)
The actions taken against the listed entity/ its promoters/ directors/ subsidiaries either by SEBI or by Stock Exchanges are specified in the last column | NA | No action(s) has been taken against 'the listed entity/ its promoters/directors/ subsidiaries either by SEBI or by Stock Exchanges. |
12 | Resignation of statutory auditors from the listed entity or its material subsidiaries:
In case of resignation of statutory auditor from the listed entity or any of its material subsidiaries during the financial year, the listed entity and / or its material subsidiary(is) has / have complied with paragraph 6.1 and 6.2 of section V-D of chapter V of the Master Circular on compliance with the provisions of the LODR Regulations by listed entities | NA | No Such resignation event happened during the period under review. |